Differential response of serum amyloid A to different therapies in early rheumatoid arthritis and its potential value as a disease activity biomarker

被引：0
|
作者：
Yong Gil Hwang
Goundappa K. Balasubramani
Ilinca D. Metes
Marc C. Levesque
S. Louis Bridges
Larry W. Moreland
机构：
[1] University of Pittsburgh,Department of Medicine, Division of Rheumatology and Clinical Immunology
[2] University of Pittsburgh,Department of Epidemiology, School of Public Health
[3] University of Alabama at Birmingham,Department of Medicine, Division of Clinical Immunology and Rheumatology Birmingham
[4] AbbVie Inc,undefined
来源：
Arthritis Research & Therapy | / 18卷
关键词：
Serum amyloid A; C-reactive protein; Early rheumatoid arthritis; Etanercept;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Serum pentraxin 3 levels in rheumatoid arthritis patients and its association with disease activity
    Jafari-Nakhjavani, Mohammadreza
    Ghorbanihaghjo, Amir
    Pourghassem, Elyar
    Abediazar, Sima
    Pourlak, Tala
    Malekmahdavi, Aida
    EGYPTIAN RHEUMATOLOGIST, 2019, 41 (04): : 251 - 254
  • [42] EVALUATION OF A MULTI-BIOMARKER DISEASE ACTIVITY (VECTRA ™ DA ALGORITHM) IN EARLY RHEUMATOID ARTHRITIS AND UNCLASSIFIED ARTHRITIS PATIENTS
    Maijer, K. I.
    de Hair, M. J. H.
    Li, W.
    Defranoux, N. A.
    Sasso, E. H.
    Gerlag, D. M.
    Tak, P. P.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 389 - 389
  • [43] CLEC12A Expression as a Potential Predictor of Disease Activity in Early Rheumatoid Arthritis
    Vaillancourt, Myriam
    Desaulniers, Philippe
    Pare, Guillaume
    Page, Nathalie
    Lachaab, Asmaa
    Kerever, Anthony
    Julien, Anne-Sophie
    Amiable, Nathalie
    Pelletier, Martin
    Tessier, Philippe
    Bessette, Louis
    Fortin, Paul
    Michou, Laetitia
    Fernandes, Maria
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [44] Serum proteomic analysis identifies interleukin 16 as a biomarker for clinical response during early treatment of rheumatoid arthritis
    Murota, Atsuko
    Suzuki, Katsuya
    Kassai, Yoshiaki
    Miyazaki, Takahiro
    Morita, Rimpei
    Kondo, Yasushi
    Takeshita, Masaru
    Niki, Yasuo
    Yoshimura, Akihiko
    Takeuchi, Tsutomu
    CYTOKINE, 2016, 78 : 87 - 93
  • [45] In Early Rheumatoid Arthritis, the Multi-Biomarker Disease Activity Score at Different Time-Points Is Predictive of Subsequent Radiographic Progression
    Hambardzumyan, Karen
    Bolce, R. J.
    Saevarsdottir, Saedis
    Forslind, Kristina
    Petersson, Ingemar F.
    Geborek, Pierre
    Sasso, Eric H.
    Chernoff, David
    Cruickshank, Scott
    van Vollenhoven, Ronald F.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S153 - S154
  • [46] CYSTEINE RICH 61 (CYR61): A POTENTIAL BIOMARKER ASSOCIATED WITH DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS
    Fan, Yong
    Yang, Xinlei
    Zhao, Juan
    Sun, Xiaoying
    Xie, Wenhui
    Huang, Yanrong
    Li Guangtao
    Hao, Yanjie
    Zhang, Zhuoli
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1578 - 1578
  • [47] Serum hyaluronan is a potential marker that correlates with the disease activity score (DAS) in patients with rheumatoid arthritis
    Kida, D.
    Tsukamoto, M.
    Sato, T.
    Kaneko, A.
    Ishihara, G.
    Sugishita, H.
    Saito, K.
    Eto, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 357 - 357
  • [48] The combined use of disease activity and infliximab serum trough concentrations for early prediction of (non-)response to infliximab in rheumatoid arthritis
    van den Bemt, Bart J. F.
    den Broeder, Alfons A.
    Wolbink, Gert-Jan
    van den Maas, Aatke
    Hekster, Yechiel A.
    van Riel, Piet L. C. M.
    Benraad, H. Bart
    van den Hoogen, Frank H. J.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 76 (06) : 939 - 945
  • [49] The Multi-Biomarker Disease Activity Score Tracks Response to Rituximab Treatment in Rheumatoid Arthritis Patients
    Roodenrijs, Nadia M. T.
    de Hair, Maria J. H.
    Wheater, Gill
    Elshahaly, Mohsen
    Tekstra, Janneke
    Teng, Y. K. Onno
    Lafeber, Floris P. J. G.
    Hwang, Ching Chang
    Liu, Xinyu
    Sasso, Eric H.
    van Laar, Jacob
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [50] THE MULTI-BIOMARKER DISEASE ACTIVITY SCORE TRACKS RESPONSE TO RITUXIMAB TREATMENT IN RHEUMATOID ARTHRITIS PATIENTS
    Roodenrijs, N. M. T.
    de Hair, M. J. H.
    Wheater, G.
    Elshahaly, M.
    Tekstra, J.
    Teng, Y. K. O.
    Hwang, C. C.
    Liu, X.
    Sasso, E. H.
    van Laar, J. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1317 - 1317
12345